LFG
REGN icon

Larson Financial Group’s Regeneron Pharmaceuticals REGN Stock Holding History

Larson Financial Group’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$391K Buy
627
+66
+12% +$44.9K 0.01% 625
2026
Q1 		$434K Buy
561
+73
+15% +$55.9K 0.01% 516
2025
Q4 		$377K Buy
488
+40
+9% +$27.2K 0.01% 548
2025
Q3 		$252K Buy
448
+271
+153% +$153K 0.01% 638
2025
Q2 		$92.9K Buy
177
+124
+234% +$69.2K ﹤0.01% 867
2025
Q1 		$33.6K Sell
53
-28
-35% -$19.3K ﹤0.01% 1171
2024
Q4 		$57.7K Buy
81
+31
+62% +$26K ﹤0.01% 861
2024
Q3 		$52.6K Buy
50
+28
+127% +$31.2K ﹤0.01% 892
2024
Q2 		$23.1K Sell
22
-28
-56% -$27.1K ﹤0.01% 1012
2024
Q1 		$48.1K Sell
50
-13
-21% -$12.4K ﹤0.01% 699
2023
Q4 		$55.3K Sell
63
-9
-13% -$7.41K ﹤0.01% 626
2023
Q3 		$59.3K Buy
72
+59
+454% +$46.4K 0.01% 567
2023
Q2 		$9.34K Hold
13
– – ﹤0.01% 957
2023
Q1 		$10.7K Hold
13
– – ﹤0.01% 907
2022
Q4 		$9.38K Hold
13
– – ﹤0.01% 877
2022
Q3 		$9K Hold
13
– – ﹤0.01% 823
2022
Q2 		$8K Sell
13
-83
-86% -$54K ﹤0.01% 787
2022
Q1 		$67K Buy
96
+22
+30% +$13.9K 0.01% 333
2021
Q4 		$47K Sell
74
-38
-34% -$23.4K 0.01% 394
2021
Q3 		$68K Hold
112
– – 0.01% 249
2021
Q2 		$63K Buy
112
+18
+19% +$9.12K 0.01% 240
2021
Q1 		$44K Hold
94
– – 0.01% 282
2020
Q4 		$45K Buy
94
+33
+54% +$17.8K 0.02% 234
2020
Q3 		$34K Buy
+61
New +$37K 0.01% 251
2020
Q1 		– Sell
-15
Closed -$6K – 638
2019
Q4 		$6K Hold
15
– – ﹤0.01% 355
2019
Q3 		$4K Hold
15
– – ﹤0.01% 387
2019
Q2 		$5K Hold
15
– – ﹤0.01% 318
2019
Q1 		$6K Hold
15
– – ﹤0.01% 277
2018
Q4 		$6K Buy
+15
New +$5.49K 0.01% 263

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Larson Financial Group's REGN Position: Q2 2026 in Review

Larson Financial Group increased its Regeneron Pharmaceuticals (REGN) stake by 12% in Q2 2026, buying an estimated $44.9K and bringing the position to 627 shares worth $391K. The position accounts for 0.01% of the portfolio, ranked #625.

Larson Financial Group first reported a position in REGN in Q4 2018 and has held it in 29 quarters since. The position peaked at $434K in Q1 2026. 1,336 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Larson Financial Group held 627 shares of Regeneron Pharmaceuticals worth $391K as of Q2 2026.
  • Larson Financial Group bought 66 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $44.9K.
  • Regeneron Pharmaceuticals made up 0.01% of Larson Financial Group's portfolio in Q2 2026, its #625 holding.
  • Larson Financial Group first reported a position in Regeneron Pharmaceuticals in Q4 2018 and has held it in 29 quarters since.
  • Larson Financial Group's Regeneron Pharmaceuticals position peaked at $434K in Q1 2026.
  • 1,336 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Larson Financial Group's 13F filing for Q2 2026, filed 14 Aug 2026.